PNLIP and obesity due to melanocortin 4 receptor deficiency: Other strategies for treating obesity and DM involve using drugs that act on target molecules, such as dipeptidyl peptidase IV, tyrosine phosphatase 1B, AMP-activated protein kinase, interleukin 6, chemokine ligand 2, and pancreatic lipase.